Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome

Clinical trial NCT05383677 · UNKNOWN

Trial details

NCT number: NCT05383677
Sponsor: University Medical Center Groningen
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Sjogren's Syndrome

Start date: 2022-10-01
Primary completion: 2024-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.